Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 26,716 followers.

RT @FrontOncology: New research: Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse even…

16 Feb 2024

Reply Repost Favourite

New research: Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event: There are very few therapeutic options to treat patients with locally advanced or metastatic Urothelial Cancer (UC).… https://t.co/qi

16 Feb 2024

Reply Repost Favourite

RT @gedefo_sefh: Case report: #Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event https://t.co/…

15 Feb 2024

Reply Repost Favourite

Case report: #Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event https://t.co/EZhwgHdbTf

15 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.